STAA — STAAR Surgical Company

STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ. It is led by Deborah J. Andrews, based in 25510 Commercentre Drive, Lake Forest, CA, United States, 92630, with about 921 employees. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Latest reported STAA revenue for 2025-09-26 was $94.7M. Net income was $8.9M. Revenue was up 113.7% from 2025-06-27 to 2025-09-26. STAA currently screens at market cap $1.45B.

Use this STAA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the STAA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the STAA SEC filings page. Lician reads the product cache first so this HTML stays unique to STAAR Surgical Company even when a live quote feed is slow.